Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Gastroenterology
Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Do You Have Ulcerative Colitis (Encinitas)
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Single Dose, Placebo Controlled Study of MDX-1100 in Patients With Active Ulcerative Colitis
The study is designed to determine how safe and effective MDX 1100 (fully human antibody) is when given to patients with active ulcerative colitis.
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis Research Study
A Phase 2 Study of Avonex in Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
The study is designed to determine how safe and effective MDX 1100 (fully human antibody) is when given to patients with active ulcerative colitis.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Do you have Ulcerative Colitis?
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Mind/Body Medicine and IBD Flare-up
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Do you suffer from Ulcerative Colitis?
Single Dose, Placebo Controlled Study of MDX-1100 in Patients With Active Ulcerative Colitis
The study is designed to determine how safe and effective MDX 1100 (fully human antibody) is when given to patients with active ulcerative colitis.
A Multicenter, Randomized, Double-Blind, Actively Controlled Trial to Evaluate the Safety and Efficacy of a New Tablet Formulation and Dosing Regimen of Balsalazide Disodium 3.3G BID vs. Mesalamine (5-ASA) as Asacol 0.8G TID
in Mildly to Moderately Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Do you or a family member suffer from Ulcerative Colitis?
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Phase 2 Study of Avonex in Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Just hanging in there with your Ulcerative Colitis?
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
How do UC Life?
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Single Dose, Placebo Controlled Study of MDX-1100 in Patients With Active Ulcerative Colitis
The study is designed to determine how safe and effective MDX 1100 (fully human antibody) is when given to patients with active ulcerative colitis.
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Children ages 6-17 with moderate to severe ulcerative colitis (UC)
Children and Adolescents with Mildly-to-Moderately Active Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects with Intravenous Steroid Refractory Ulcerative Colitis [291-415]
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects with Intravenous Steroid Refractory Ulcerative Colitis [291-415]
A Phase I, Blinded, Multicenter, Dose-escalation, Placebo-controlled, Single-dose Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Patients with Active Ulcerative Colitis [MDX1100-01]
A Phase I, Multicenter, Dose-escalation, Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Patients with Active Ulcerative Colitis [MDX1100-01]
Clinical Study for Patients with Active Ulcerative Colitis (UC)
Single Dose, Placebo Controlled Study of MDX-1100 in Patients With Active Ulcerative Colitis
The study is designed to determine how safe and effective MDX 1100 (fully human antibody) is when given to patients with active ulcerative colitis.
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Efficacy and safety of new oral budesonide-MMX™ (CB-01-02) 6 mg and 9 mg extended release tablet formulations in patients with mild or moderate, active ulcerative colitis. A multicenter, randomized, double-blind, double dummy comparative study versus placebo, with an additional reference arm evaluating Asacol® 2400 mg.
M06-826 - A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Moderately to Severely Active Ulcerative Colitis.
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Do you have ulcerative colitis in remission?
Just hanging in there with your Ulcerative Colitis?
Ulcerative Colitis?
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
ULCERATIVE COLITIS: If your stomach pain is due to Ulcerative Colitis, there's plenty of help available.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
An Ulcerative Colitis Research Study
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis - Houston, TX
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
(CB-01-02/01)Randomized Placebo Controlled Trial of Budesonide-MMX™ (CB-01-02) 6 mg and 9 mg in Patients With Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of XXXXXXXXX Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis.
A Clinical Trial for Individuals with Mild to Moderate Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
A Phase 2 Study of Avonex in Ulcerative Colitis
